Author:
Pandya Deep,Camacho Sandra Catalina,Padron Maria M.,Camacho-Vanegas Olga,Billaud Jean-Noel,Beddoe Ann-Marie,Irish Jon,Yoxtheimer Lorene,Kalir Tamara,RoseFigura Jordan,Dottino Peter,Martignetti John A.
Abstract
Epithelial ovarian cancer (OvCa) is the most lethal female reproductive tract malignancy. A major clinical hurdle in patient management and treatment is that when using current surveillance technologies 80% of patients will be clinically diagnosed as having had a complete clinical response to primary therapy. In fact, the majority of women nonetheless develop disease recurrence within 18 mo. Thus, without more accurate surveillance protocols, the diagnostic question regarding OvCa recurrence remains framed as “when” rather than “if.” With this background, we describe the case of a 61-yr-old female who presented with a 3-mo history of unexplained whole-body rash, which unexpectedly led to a diagnosis of and her treatment for OvCa. The rash resolved immediately following debulking surgery. Nearly 1 yr later, however, the rash reappeared, prompting the prospect of tumor recurrence and requirement for additional chemotherapy. To investigate this possibility, we undertook a genomics-based tumor surveillance approach using a targeted 56-gene NGS panel and biobanked tumor samples to develop personalized ctDNA biomarkers. Although tumor-specific TP53 and PTEN mutations were detectable in all originally collected tumor samples, pelvic washes, and blood samples, they were not detectable in any biosample collected beyond the first month of treatment. No additional chemotherapy was given. The rash spontaneously resolved. Now, 2 yr beyond the patient's original surgery, and in the face of continued negative ctDNA findings, the patient remains with no evidence of disease. As this single case report suggests, we believe for the first time that ctDNA can provide an additional layer of information to avoid overtreatment.
Publisher
Cold Spring Harbor Laboratory
Reference29 articles.
1. Armstrong D , Axilbund J , Bell J , Bristow R , Chi D , Diaz-Montes T , Eitan R , Ferriss J , Giuntoli R , Gross A , 2010. Epidemiology and clinical presentation of ovarian cancer. In Early diagnosis and treatment of cancer series: ovarian cancer (ed. Bristow R , Armstrong D ), pp. 1–15. Saunders, Philadelphia.
2. Dermatomyositis as a paraneoplastic phenomenon in ovarian cancer
3. CA 125 and the detection of recurrent ovarian cancer
4. Radiological Assessment of Gynecologic Malignancies
5. Cancer Stat Facts: Ovarian Cancer. 2019. SEER Cancer Statistics Review. National Cancer Institute, Bethesda, MD.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献